Itay Tokatly Latzer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Amino Acid Metabolism, Inborn Errors | 7 | 2024 | 284 | 4.420 |
Why?
|
| Succinate-Semialdehyde Dehydrogenase | 6 | 2024 | 96 | 2.860 |
Why?
|
| Developmental Disabilities | 7 | 2024 | 1519 | 1.550 |
Why?
|
| Pseudotumor Cerebri | 2 | 2023 | 107 | 1.420 |
Why?
|
| Epilepsy | 6 | 2023 | 3317 | 1.370 |
Why?
|
| gamma-Aminobutyric Acid | 6 | 2024 | 1140 | 1.150 |
Why?
|
| Spinal Muscular Atrophies of Childhood | 3 | 2023 | 116 | 1.130 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2019 | 239 | 1.080 |
Why?
|
| Bloodletting | 1 | 2023 | 22 | 0.870 |
Why?
|
| Muscular Atrophy, Spinal | 2 | 2023 | 260 | 0.820 |
Why?
|
| Sodium Oxybate | 1 | 2023 | 36 | 0.820 |
Why?
|
| Stenotrophomonas maltophilia | 2 | 2019 | 18 | 0.800 |
Why?
|
| alpha-Glucosidases | 1 | 2021 | 46 | 0.730 |
Why?
|
| Glycogen Storage Disease Type II | 1 | 2021 | 43 | 0.720 |
Why?
|
| Intracranial Hypertension | 1 | 2023 | 190 | 0.700 |
Why?
|
| Celiac Disease | 2 | 2018 | 820 | 0.690 |
Why?
|
| Encephalocele | 1 | 2021 | 135 | 0.660 |
Why?
|
| Apgar Score | 1 | 2019 | 125 | 0.660 |
Why?
|
| Trimethoprim | 1 | 2019 | 79 | 0.640 |
Why?
|
| Sulfadoxine | 1 | 2019 | 47 | 0.640 |
Why?
|
| Minocycline | 1 | 2019 | 169 | 0.590 |
Why?
|
| Ciprofloxacin | 1 | 2019 | 314 | 0.560 |
Why?
|
| Menstruation | 1 | 2018 | 310 | 0.550 |
Why?
|
| Israel | 6 | 2022 | 729 | 0.530 |
Why?
|
| Diet, Gluten-Free | 1 | 2018 | 285 | 0.510 |
Why?
|
| Induced Pluripotent Stem Cells | 2 | 2024 | 1884 | 0.490 |
Why?
|
| Amenorrhea | 1 | 2018 | 470 | 0.490 |
Why?
|
| Cerebral Palsy | 1 | 2019 | 481 | 0.470 |
Why?
|
| Child | 21 | 2024 | 80573 | 0.470 |
Why?
|
| Refugees | 1 | 2023 | 615 | 0.470 |
Why?
|
| Electric Impedance | 1 | 2018 | 792 | 0.450 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2023 | 83 | 0.410 |
Why?
|
| Suicide | 1 | 2023 | 1606 | 0.400 |
Why?
|
| Inpatients | 2 | 2020 | 2566 | 0.380 |
Why?
|
| Child, Preschool | 11 | 2024 | 42511 | 0.380 |
Why?
|
| Activities of Daily Living | 1 | 2021 | 2419 | 0.370 |
Why?
|
| Brain Diseases | 1 | 2020 | 1552 | 0.370 |
Why?
|
| Education, Special | 2 | 2021 | 86 | 0.360 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 7474 | 0.340 |
Why?
|
| Adaptation, Psychological | 1 | 2021 | 2662 | 0.340 |
Why?
|
| Anorexia Nervosa | 1 | 2018 | 1328 | 0.330 |
Why?
|
| Spasms, Infantile | 1 | 2023 | 300 | 0.330 |
Why?
|
| Feeding Behavior | 2 | 2018 | 3209 | 0.320 |
Why?
|
| Seizures | 4 | 2023 | 2997 | 0.300 |
Why?
|
| Disease Management | 1 | 2018 | 2531 | 0.290 |
Why?
|
| Metabolic Diseases | 1 | 2023 | 686 | 0.270 |
Why?
|
| Parents | 1 | 2021 | 3591 | 0.270 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2019 | 3445 | 0.270 |
Why?
|
| Adolescent | 12 | 2024 | 88819 | 0.270 |
Why?
|
| Adipose Tissue | 1 | 2018 | 3315 | 0.270 |
Why?
|
| Anxiety | 1 | 2021 | 4672 | 0.260 |
Why?
|
| Electroencephalography | 2 | 2023 | 6279 | 0.260 |
Why?
|
| Stress, Psychological | 1 | 2021 | 4527 | 0.250 |
Why?
|
| Humans | 35 | 2024 | 766117 | 0.230 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2023 | 36548 | 0.230 |
Why?
|
| Infant | 6 | 2023 | 36427 | 0.230 |
Why?
|
| Internship and Residency | 2 | 2021 | 5946 | 0.220 |
Why?
|
| Female | 22 | 2024 | 396233 | 0.210 |
Why?
|
| Aquaporin 4 | 1 | 2023 | 161 | 0.210 |
Why?
|
| Oligonucleotides | 2 | 2022 | 561 | 0.200 |
Why?
|
| Laryngostenosis | 1 | 2023 | 168 | 0.190 |
Why?
|
| Intensive Care Units, Pediatric | 2 | 2019 | 1021 | 0.190 |
Why?
|
| Depression | 1 | 2021 | 8230 | 0.190 |
Why?
|
| Male | 19 | 2024 | 363935 | 0.190 |
Why?
|
| Biomarkers, Pharmacological | 1 | 2022 | 161 | 0.190 |
Why?
|
| Prevalence | 4 | 2023 | 15827 | 0.180 |
Why?
|
| Respiratory Paralysis | 1 | 2019 | 32 | 0.160 |
Why?
|
| Medical Staff | 1 | 2019 | 40 | 0.160 |
Why?
|
| Child Development | 2 | 2021 | 2327 | 0.160 |
Why?
|
| Neonatal Screening | 1 | 2023 | 619 | 0.150 |
Why?
|
| Diaphragm | 1 | 2019 | 357 | 0.140 |
Why?
|
| Neurologic Examination | 1 | 2021 | 913 | 0.140 |
Why?
|
| Comorbidity | 3 | 2021 | 10579 | 0.140 |
Why?
|
| Patient Care Management | 1 | 2019 | 301 | 0.130 |
Why?
|
| Critical Illness | 2 | 2019 | 2749 | 0.130 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2022 | 3719 | 0.120 |
Why?
|
| Brain | 4 | 2024 | 27177 | 0.120 |
Why?
|
| Infant, Newborn | 3 | 2023 | 26381 | 0.120 |
Why?
|
| Hospitalization | 3 | 2019 | 10811 | 0.120 |
Why?
|
| Consensus | 1 | 2024 | 3202 | 0.110 |
Why?
|
| Anthropometry | 1 | 2018 | 1339 | 0.110 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2023 | 3678 | 0.110 |
Why?
|
| Immunocompromised Host | 1 | 2019 | 865 | 0.110 |
Why?
|
| Central Nervous System Stimulants | 1 | 2022 | 1167 | 0.110 |
Why?
|
| Medical Records | 1 | 2018 | 1408 | 0.100 |
Why?
|
| Drug Combinations | 1 | 2019 | 2076 | 0.100 |
Why?
|
| Resilience, Psychological | 1 | 2021 | 808 | 0.100 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2018 | 1971 | 0.100 |
Why?
|
| Genetic Association Studies | 1 | 2021 | 2744 | 0.090 |
Why?
|
| Retrospective Studies | 5 | 2020 | 81565 | 0.090 |
Why?
|
| Autistic Disorder | 1 | 2021 | 1238 | 0.090 |
Why?
|
| Bariatric Surgery | 1 | 2019 | 997 | 0.080 |
Why?
|
| Cross Infection | 1 | 2018 | 1427 | 0.080 |
Why?
|
| Risk Factors | 4 | 2019 | 74857 | 0.080 |
Why?
|
| Obesity, Morbid | 1 | 2019 | 1293 | 0.080 |
Why?
|
| Patient Compliance | 1 | 2018 | 2694 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2023 | 54812 | 0.070 |
Why?
|
| Sex Factors | 2 | 2020 | 10614 | 0.070 |
Why?
|
| Curriculum | 1 | 2021 | 3784 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 7424 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2022 | 3787 | 0.070 |
Why?
|
| Attitude of Health Personnel | 1 | 2020 | 3928 | 0.060 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2021 | 3682 | 0.060 |
Why?
|
| Phenotype | 1 | 2023 | 16716 | 0.060 |
Why?
|
| Diet | 1 | 2023 | 8087 | 0.060 |
Why?
|
| Body Mass Index | 2 | 2022 | 13046 | 0.060 |
Why?
|
| Young Adult | 3 | 2021 | 59868 | 0.060 |
Why?
|
| Disease Models, Animal | 1 | 2024 | 18321 | 0.060 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 4054 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2021 | 4712 | 0.060 |
Why?
|
| Disease Progression | 1 | 2021 | 13616 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22228 | 0.050 |
Why?
|
| Clinical Competence | 1 | 2019 | 4859 | 0.050 |
Why?
|
| Adult | 5 | 2021 | 223139 | 0.050 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 14747 | 0.050 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 39243 | 0.050 |
Why?
|
| Quality of Life | 2 | 2021 | 13468 | 0.050 |
Why?
|
| Injections, Spinal | 1 | 2022 | 318 | 0.050 |
Why?
|
| Age Factors | 1 | 2018 | 18386 | 0.050 |
Why?
|
| Pandemics | 1 | 2021 | 8725 | 0.040 |
Why?
|
| Religion and Sex | 1 | 2020 | 2 | 0.040 |
Why?
|
| Secularism | 1 | 2020 | 2 | 0.040 |
Why?
|
| Incidence | 1 | 2018 | 21513 | 0.040 |
Why?
|
| Glucuronidase | 1 | 2021 | 205 | 0.040 |
Why?
|
| Pregnancy | 1 | 2021 | 30233 | 0.040 |
Why?
|
| Cultural Characteristics | 1 | 2020 | 250 | 0.040 |
Why?
|
| Muscles | 1 | 2022 | 1576 | 0.040 |
Why?
|
| Mice | 1 | 2024 | 81839 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2023 | 65219 | 0.030 |
Why?
|
| Mutation | 1 | 2021 | 30209 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2021 | 1097 | 0.030 |
Why?
|
| Animals | 1 | 2024 | 168800 | 0.020 |
Why?
|
| Glucose | 1 | 2022 | 4335 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2020 | 26290 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8724 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2020 | 9657 | 0.020 |
Why?
|
| Neurons | 1 | 2023 | 9521 | 0.010 |
Why?
|
| Obesity | 1 | 2022 | 13085 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2021 | 15808 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 223083 | 0.000 |
Why?
|